Knowledge Attitude and Practice Regarding Bloodstream Bacterial Infections and Antibiotics Usage Among Doctors.

NCT06605677 | Enrolling By Invitation

• 1 other identifier: HREC SEHA-IRB-559
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

This study is designed to use a questionnaire to assess doctors' knowledge, attitudes, and practices regarding bloodstream bacterial infections and antibiotic use in Tawam and Al Ain tertiary Hospitals (both hospitals have the same medical team) in Al Ain City, UAE.

Conditions

Bacteremia; Antimicrobial Stewardship; Antibiotic Use; Antibiotic Abuse

Keywords

bacteremia; antimicrobial resistance; antimicrobial stewardship; healthcare workers; antibiotic use; antibiotic abuse

Outcome Measures

Primary Outcomes (3)

• Understanding physician knowledge on antibiotic use in bacterial bloodstream infections (bacteremia).

  Questions to assess physicians' knowledge related to basic microbiology, bacterial infections and antibiotic spectrum of activity using dichotomous questions; yes/no.

  1 year

• Understanding physician attitude on antibiotic use in bacterial bloodstream infections (bacteremia).

  Questions to assess physicians' attitude in bacteremia management using dichotomous questions; yes/no, Likert scale or multiple choices.

  1 year

• Understanding physician practices on antibiotic use in bacterial bloodstream infections (bacteremia).

  Questions to assess physicians' practice in bacteremia management using dichotomous questions; yes/no, or multiple choices.

  1 year

Study Arms (1)

All doctors with valid medical license in Tawam and Al Ain Hospitals

The group excludes infectious disease physicians and microbiologists.

Other: Questionnaire

Interventions

Questionnaire OTHER

An online questionnaire will be sent through e-mail to participants. It is divided into 4 sections: demography and general information 9 questions, knowledge 10 questions, attitude 10 questions and practice 10 questions. No previous similar studies were conducted in the United Arab Emirates (UAE) or internationally based on a search in PubMed and Cochrane library. Hence a validated questionnaire is lacking. Therefore, the questionnaire for this study is designed based on questions encountered daily by colleagues during the consultation, and it can serve the purpose of this study. Consent will be obtained and signed electronically by participants before starting the questionnaire. Participation involves minimal risk. Responses will be anonymous and confidential. Participants' involvement is voluntary, and they can withdraw at any time without any consequences. The time to complete the questionnaire is around 10-15 minutes. Each response will be saved using a unique identifier number.

All doctors with valid medical license in Tawam and Al Ain Hospitals

Eligibility Criteria

• Sex: all
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Licensed, practicing physicians, multinational

You may qualify if:

• All physicians with valid medical licenses working in Tawam and Al Ain tertiary hospitals

You may not qualify if:

• Infectious diseases physicians and Microbiologists

Sponsors & Collaborators

• Abu Dhabi Health Services Company: lead

Study Sites (1)

Tawam and Al Ain Hospital

Al Ain City, United Arab Emirates

Location

Related Publications (5)

• Thomsen J et al. United Arab Emirates Surveillance of Antimicrobial Resistance Annual Report 2022.

  RESULT

• Labelle A, Juang P, Reichley R, Micek S, Hoffmann J, Hoban A, Hampton N, Kollef M. The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment*. Crit Care Med. 2012 Jul;40(7):2016-21. doi: 10.1097/CCM.0b013e318250aa72.

  PMID: 22584765 RESULT

• Zahar JR, Timsit JF, Garrouste-Orgeas M, Francais A, Vesin A, Descorps-Declere A, Dubois Y, Souweine B, Haouache H, Goldgran-Toledano D, Allaouchiche B, Azoulay E, Adrie C. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality. Crit Care Med. 2011 Aug;39(8):1886-95. doi: 10.1097/CCM.0b013e31821b827c.

  PMID: 21516036 RESULT

• Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med. 1980 Mar;68(3):344-55. doi: 10.1016/0002-9343(80)90102-3.

  PMID: 6987871 RESULT

• Bearman GM, Wenzel RP. Bacteremias: a leading cause of death. Arch Med Res. 2005 Nov-Dec;36(6):646-59. doi: 10.1016/j.arcmed.2005.02.005.

  PMID: 16216646 RESULT

MeSH Terms

Conditions

Bacteremia

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Bacterial Infections; Bacterial Infections and Mycoses; Infections; Sepsis; Systemic Inflammatory Response Syndrome; Inflammation; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Noura Saif Alnuaimi, MD

  Abu Dhabi Health Services Co-SEHA

  PRINCIPAL INVESTIGATOR

• Ahmed Al Hammadi, MD

  Abu Dhabi Health Services Co-SEHA

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Consutant Physician Internist

Study Record Dates

• First Submitted: September 18, 2024
• First Posted: September 20, 2024
• Study Start: September 9, 2024
• Primary Completion: March 9, 2025
• Study Completion: March 9, 2025
• Last Updated: September 26, 2024

Record last verified: 2024-09

Data Sharing

• IPD Sharing: Will not share

Locations

AE (1)